Temat: "Breast Neoplasms" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Native American ancestry and breast cancer risk in Colombian and Mexican women: ruling out potential confounding through ancestry-informative markers.
Autorzy:: Zollner L; Statistical Genetics Research Group, Institute of Medical Biometry, Heidelberg University, Heidelberg, Germany.; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120, Heidelberg, Germany.; Division of Proteomics of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Torres D; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120, Heidelberg, Germany.; Institute of Human Genetics, Pontificia Universidad Javeriana, Bogotá, Colombia.
Briceno I; Instituto de Genética Humana, Universidad de la Sabana, Bogotá, Colombia.
Gilbert M; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120, Heidelberg, Germany.
Torres-Mejía G; Center for Population Health Research, National Institute of Public Health, Cuernavaca, Morelos, Mexico.
Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120, Heidelberg, Germany. .
Lorenzo Bermejo J; Statistical Genetics Research Group, Institute of Medical Biometry, Heidelberg University, Heidelberg, Germany.; Department of Biostatistics for Precision Oncology, Institut de Cancérologie Strasbourg Europe, Strasbourg, France.; Pokaż więcej
Źródło:: Breast cancer research : BCR [Breast Cancer Res] 2023 Oct 02; Vol. 25 (1), pp. 111. Date of Electronic Publication: 2023 Oct 02.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:: American Indian or Alaska Native*/ethnology
American Indian or Alaska Native*/genetics
American Indian or Alaska Native*/statistics & numerical data
Breast Neoplasms*/epidemiology
Breast Neoplasms*/ethnology
Breast Neoplasms*/genetics
Female ; Humans ; Breast ; Colombia/epidemiology ; Mexico/epidemiology ; Triple Negative Breast Neoplasms/epidemiology ; Triple Negative Breast Neoplasms/ethnology ; Triple Negative Breast Neoplasms/genetics

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 2.

Tytuł:: Trichorhinophalangeal syndrome type 1 (TRPS1) expression in male breast carcinoma.
Autorzy:: Law T; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Piotrowski MJ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston TX 77030, USA.
Ning J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Jiang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Ding Q; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: .
Sahin AA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: .; Pokaż więcej
Źródło:: Human pathology [Hum Pathol] 2023 Aug; Vol. 138, pp. 62-67. Date of Electronic Publication: 2023 Jun 16.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*
Breast Neoplasms, Male*/genetics
Female ; Humans ; Male ; Biomarkers, Tumor ; GATA3 Transcription Factor ; Hair Diseases ; Langer-Giedion Syndrome ; Receptors, Estrogen ; Repressor Proteins ; Triple Negative Breast Neoplasms
SCR Disease Name:: Trichorhinophalangeal Syndrome, Type I

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 3.

Tytuł:: Preoperative considerations and benefits of neoadjuvant chemotherapy: insights from a 12-year review of the Hong Kong Breast Cancer Registry.
Autorzy:: Chan YHY; Department of Surgery, Kwong Wah Hospital, Hong Kong SAR, China.
Kwok CCH; Department of Oncology, Princess Margaret Hospital, Hong Kong SAR, China.
Tse DMS; Breast Cancer Research Centre, Hong Kong Breast Cancer Foundation, Hong Kong SAR, China.
Lee HM; Breast Cancer Research Centre, Hong Kong Breast Cancer Foundation, Hong Kong SAR, China.
Tam PY; Breast Cancer Research Centre, Hong Kong Breast Cancer Foundation, Hong Kong SAR, China.
Cheung PSY; Breast Cancer Research Centre, Hong Kong Breast Cancer Foundation, Hong Kong SAR, China.; Pokaż więcej
Źródło:: Hong Kong medical journal = Xianggang yi xue za zhi [Hong Kong Med J] 2023 Jun; Vol. 29 (3), pp. 198-207. Date of Electronic Publication: 2023 Apr 06.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/therapy
Neoadjuvant Therapy*
Humans ; Female ; Hong Kong ; Receptor, ErbB-2 ; Triple Negative Breast Neoplasms ; Treatment Outcome ; Adult ; Middle Aged ; Aged

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 4.

Tytuł:: The association of race/ethnicity in male breast cancer survival within similar comorbidity cohorts.
Autorzy:: Parise CA; Sutter Center for Health Systems Research, Sacramento, California, USA.; Sutter Institute for Medical Research, Sacramento, California, USA.
Caggiano V; Sutter Institute for Medical Research, Sacramento, California, USA.; Pokaż więcej
Źródło:: Cancer [Cancer] 2023 Mar 01; Vol. 129 (5), pp. 750-763. Date of Electronic Publication: 2023 Jan 03.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Research Support, N.I.H., Extramural
MeSH Terms:: Breast Neoplasms, Male*/ethnology
Breast Neoplasms, Male*/mortality
Female ; Humans ; Male ; Breast Neoplasms ; Comorbidity ; Ethnicity ; Hispanic or Latino ; Minority Groups ; California/epidemiology ; Registries

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 5.

Tytuł:: Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers.
Autorzy:: Clark NM; Department of Surgery, University of Washington, Seattle, USA.
Roberts EA; University of Washington School of Medicine, Seattle, USA.
Fedorenko C; Hutchinson Institute for Cancer Outcomes Research Fred Hutchinson Cancer Center, Seattle, USA.
Sun Q; Hutchinson Institute for Cancer Outcomes Research Fred Hutchinson Cancer Center, Seattle, USA.
Dubard-Gault M; Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, USA.; Fred Hutchinson Cancer Center, Seattle, USA.
Handford C; Fred Hutchinson Cancer Center, Seattle, USA.
Yung R; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, USA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, USA.
Cheng HH; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, USA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, USA.
Sham JG; Department of Surgery, University of Washington, Seattle, USA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, USA.
Norquist BM; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, Seattle, USA.
Flanagan MR; Department of Surgery, University of Washington, Seattle, USA. .; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, USA. .; Pokaż więcej
Źródło:: Annals of surgical oncology [Ann Surg Oncol] 2023 Mar; Vol. 30 (3), pp. 1312-1326. Date of Electronic Publication: 2022 Nov 05.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/genetics
Genetic Testing*
Ovarian Neoplasms*/genetics
Prostatic Neoplasms*/genetics
Pancreatic Neoplasms*/genetics
Female ; Humans ; Male ; Genetic Counseling ; Pancreatic Hormones ; Retrospective Studies ; Triple Negative Breast Neoplasms/genetics ; Triple Negative Breast Neoplasms/pathology

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 6.

Tytuł:: Machine learning analysis of breast ultrasound to classify triple negative and HER2+ breast cancer subtypes.
Autorzy:: Ferre R; Department of Medical Imaging, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Elst J; Department of Medical Imaging, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Senthilnathan S; Department of Medical Imaging, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Lagree A; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Tabbarah S; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Lu FI; Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Sadeghi-Naini A; Department of Electrical Engineering and Computer Science, York University, Toronto, ON, Canada.
Tran WT; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; Temerty Centre for AI Research and Education, University of Toronto, ON, Canada.
Curpen B; Department of Medical Imaging, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Department of Medical Imaging, University of Toronto, Toronto, ON, Canada.; Pokaż więcej
Źródło:: Breast disease [Breast Dis] 2023; Vol. 42 (1), pp. 59-66.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/metabolism
Breast Neoplasms*/pathology
Machine Learning*
Ultrasonography*
Female ; Humans ; Pilot Projects ; Receptor, ErbB-2/metabolism ; Retrospective Studies ; Triple Negative Breast Neoplasms/diagnostic imaging ; Middle Aged

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Short-term follow-up of contrast-enhanced mammography lesions after negative breast MRI in women with elevated breast cancer risk.
Autorzy:: Coffey K; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States. Electronic address: .
Dixon LB; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States.
Sevilimedu V; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States.
Jochelson MS; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States.
Sung JS; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States.; Pokaż więcej
Źródło:: European journal of radiology [Eur J Radiol] 2023 Nov; Vol. 168, pp. 111097. Date of Electronic Publication: 2023 Sep 16.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/epidemiology
Triple Negative Breast Neoplasms*
Female ; Humans ; Middle Aged ; Retrospective Studies ; Follow-Up Studies ; Mammography/methods ; Magnetic Resonance Imaging/methods

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 8.

Tytuł:: Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development.
Autorzy:: Nikolaienko O; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway.
Eikesdal HP; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway.
Ognedal E; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway.
Gilje B; Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway.
Lundgren S; Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Blix ES; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.
Espelid H; Department of Surgery, Haugesund Hospital, Haugesund, Norway.
Geisler J; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Geisler S; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.
Janssen EAM; Department of Pathology, Stavanger University Hospital, Stavanger, Norway.; Department of Chemistry, Bioscience and Environmental Engineering, Stavanger University, Stavanger, Norway.
Yndestad S; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway.
Minsaas L; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway.
Leirvaag B; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway.
Lillestøl R; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway.
Knappskog S; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway.
Lønning PE; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway. .; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway. .; Pokaż więcej
Źródło:: Genome medicine [Genome Med] 2023 Dec 06; Vol. 15 (1), pp. 104. Date of Electronic Publication: 2023 Dec 06.
Typ publikacji:: Journal Article
MeSH Terms:: Triple Negative Breast Neoplasms*/genetics
Triple Negative Breast Neoplasms*/pathology
Breast Neoplasms*/genetics
Adult ; Female ; Infant, Newborn ; Humans ; DNA Methylation ; Promoter Regions, Genetic ; BRCA1 Protein/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: A Case Report of a Rare ER+, PR- Pure Metaplastic Breast Squamous Cell Carcinoma with HER2 Overexpression.
Autorzy:: Adam SA; Department of Primary Care Medicine, Faculty of Medicine, Universiti Teknologi MARA (UiTM), Selangor, Malaysia.
Kamaruddin KN; Department of Primary Care Medicine, Faculty of Medicine, Universiti Teknologi MARA (UiTM), Selangor, Malaysia.
Abd Shukor N; Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur, Malaysia.
Abdullah Suhaimi SN; Department of Surgery, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur, Malaysia.
Ismail F; Department of Radiotherapy & Oncology, Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur, Malaysia.
Md Yasin M; Department of Primary Care Medicine, Faculty of Medicine, Universiti Teknologi MARA (UiTM), Selangor, Malaysia.; Pokaż więcej
Źródło:: The American journal of case reports [Am J Case Rep] 2023 Dec 04; Vol. 24, pp. e941448. Date of Electronic Publication: 2023 Dec 04.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Breast Neoplasms*/therapy
Breast Neoplasms*/diagnosis
Carcinoma, Squamous Cell*/diagnosis
Carcinoma, Squamous Cell*/therapy
Triple Negative Breast Neoplasms*
Female ; Humans ; Adult ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/metabolism ; Mastectomy

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Factors affecting the economic burden of breast cancer in southern Iran.
Autorzy:: Jalali FS; Student Research Committee, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Seif M; Non-communicable Disease Research Center, Department of Epidemiology, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Jafari A; Health Human Resources Research Centre, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Zangouri V; Breast Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Keshavarz K; Health Human Resources Research Centre, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran. .
Ravangard R; Health Human Resources Research Centre, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran. ra_.; Pokaż więcej
Źródło:: BMC health services research [BMC Health Serv Res] 2023 Dec 01; Vol. 23 (1), pp. 1332. Date of Electronic Publication: 2023 Dec 01.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/diagnosis
Breast Neoplasms*/therapy
Humans ; Female ; Iran/epidemiology ; Cost of Illness ; Financial Stress ; Income

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Added value of clinical decision rules for the management of enhancing breast MRI lesions: A systematic comparison of the Kaiser score and the Göttingen score.
Autorzy:: Dietzel M; Department of Radiology, University Hospital Erlangen, Maximiliansplatz 3, 91054 Erlangen, Germany. Electronic address: .
Bernathova M; Department of Biomedical Imaging and Image-Guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Waehringer-Guertel 18-20, Vienna, Austria. Electronic address: .
Clauser P; Department of Biomedical Imaging and Image-Guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Waehringer-Guertel 18-20, Vienna, Austria. Electronic address: .
Kapetas P; Department of Biomedical Imaging and Image-Guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Waehringer-Guertel 18-20, Vienna, Austria. Electronic address: .
Uder M; Department of Radiology, University Hospital Erlangen, Maximiliansplatz 3, 91054 Erlangen, Germany. Electronic address: .
Baltzer PAT; Department of Biomedical Imaging and Image-Guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Waehringer-Guertel 18-20, Vienna, Austria. Electronic address: .; Pokaż więcej
Źródło:: European journal of radiology [Eur J Radiol] 2023 Dec; Vol. 169, pp. 111185. Date of Electronic Publication: 2023 Nov 04.
Typ publikacji:: Journal Article
MeSH Terms:: Clinical Decision Rules*
Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/pathology
Male ; Humans ; Middle Aged ; Retrospective Studies ; Magnetic Resonance Imaging/methods ; Breast/diagnostic imaging ; Breast/pathology ; Image-Guided Biopsy ; Sensitivity and Specificity

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 12.

Tytuł:: Correlation between the CEM imaging characteristics and different molecular subtypes of breast cancer.
Autorzy:: Li N; Department of Medical Imaging, Affiliated Hospital of Jining Medical University, Jining, 272000, China. Electronic address: .
Gong W; Clinic Imaging Center, The Affiliated Tai'an City Central Hospital of Qingdao University, Tai'an, 271000, China.
Xie Y; Clinic Imaging Center, The Affiliated Tai'an City Central Hospital of Qingdao University, Tai'an, 271000, China.
Sheng L; Clinic Imaging Center, The Affiliated Tai'an City Central Hospital of Qingdao University, Tai'an, 271000, China. Electronic address: .; Pokaż więcej
Źródło:: Breast (Edinburgh, Scotland) [Breast] 2023 Dec; Vol. 72, pp. 103595. Date of Electronic Publication: 2023 Oct 31.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/diagnosis
Triple Negative Breast Neoplasms*/pathology
Calcinosis*/diagnostic imaging
Female ; Humans ; Retrospective Studies ; Mammography ; Receptor, ErbB-2 ; Prognosis ; Lymph Nodes/diagnostic imaging ; Lymph Nodes/pathology

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 13.

Tytuł:: Characterisation of luminal and triple-negative breast cancer with HER2 Low protein expression.
Autorzy:: Atallah NM; Translational Medical Science, School of Medicine, the University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK; Department of Pathology, Faculty of Medicine, Menoufia University, Egypt.
Haque M; School of Veterinary Medicine and Sciences, University of Nottingham, Sutton Bonington, UK.
Quinn C; University College Dublin, School of Medicine, St Vincent's Hospital, Elm Park, Dublin, Ireland.
Toss MS; Translational Medical Science, School of Medicine, the University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK; Histopathology Department, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Makhlouf S; Translational Medical Science, School of Medicine, the University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK; Department of Pathology, Faculty of Medicine, Assiut University, Egypt.
Ibrahim A; Translational Medical Science, School of Medicine, the University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK; Department of Pathology, Suez Canal University, Egypt.
Green AR; Translational Medical Science, School of Medicine, the University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK.
Alsaleem M; School of Veterinary Medicine and Sciences, University of Nottingham, Sutton Bonington, UK; Unit of Scientific Research, Applied College, Qassim University, Saudi Arabia.
Rutland CS; School of Veterinary Medicine and Sciences, University of Nottingham, Sutton Bonington, UK.
Allegrucci C; School of Veterinary Medicine and Sciences, University of Nottingham, Sutton Bonington, UK; Nottingham Breast Cancer Research Centre, Biodiscovery Institute, Nottingham, UK.
Mongan NP; School of Veterinary Medicine and Sciences, University of Nottingham, Sutton Bonington, UK; Department of Pharmacology, Weill Cornell Medicine, New York, NY, 10065, USA.
Rakha E; Translational Medical Science, School of Medicine, the University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK; Department of Pathology, Faculty of Medicine, Menoufia University, Egypt; Pathology Department, Hamad Medical Corporation, Doha, Qatar. Electronic address: .; Pokaż więcej
Źródło:: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Dec; Vol. 195, pp. 113371. Date of Electronic Publication: 2023 Oct 07.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/drug therapy
Female ; Humans ; Prognosis ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 14.

Tytuł:: Trends in the pre-operative diagnosis and surgical management of axillary lymph node metastases in women with screen-detected breast cancer.
Autorzy:: Duijm LEM; Department of Radiology, Canisius Wilhelmina Hospital, Weg door Jonkerbos 100, 6532, SZ, Nijmegen, the Netherlands.
Strobbe LJA; Department of Surgical Oncology, Canisius Wilhelmina Hospital, Weg door Jonkerbos 100, 6532, SZ, Nijmegen, the Netherlands.
van Breest Smallenburg V; Department of Radiology, Jeroen Bosch Hospital, Henri Dunantstraat 1, 5223, GZ, 's-Hertogenbosch, the Netherlands.
Op de Coul-Froger CL; Department of Radiology, Bernhoven Hospital, Nistelrodeseweg 10, 5406, PT, Uden, the Netherlands.
Setz-Pels W; Department of Radiology, Catharina Hospital, Michelangelolaan 2, 5623, EJ, Eindhoven, the Netherlands.
Vreuls W; Department of Pathology, Canisius Wilhelmina Hospital, Weg door Jonkerbos 100, 6532, SZ, Nijmegen, the Netherlands.
van Beek HC; Department of Radiology, Maxima Medical Center, De Run 4600, 5504, DB Veldhoven, the Netherlands.
van Bommel RMG; Department of Radiology, St Anna Hospital, Bogardeind 2, 5664, EH, Geldrop, the Netherlands.
Voogd AC; Department of Epidemiology, Maastricht University, PO Box 616, 6200, MD, Maastricht, the Netherlands. Electronic address: .; Pokaż więcej
Źródło:: Breast (Edinburgh, Scotland) [Breast] 2023 Dec; Vol. 72, pp. 103593. Date of Electronic Publication: 2023 Oct 21.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/surgery
Breast Neoplasms*/pathology
Female ; Humans ; Lymphatic Metastasis/pathology ; Sentinel Lymph Node Biopsy/methods ; Mammography ; Early Detection of Cancer ; Lymph Nodes/diagnostic imaging ; Lymph Nodes/surgery ; Lymph Nodes/pathology ; Lymph Node Excision ; Axilla/pathology

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 15.

Tytuł:: Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16).
Autorzy:: Kim SH; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
Im SA; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University, College of Medicine, Seoul, South Korea.
Suh KJ; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
Lee KH; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University, College of Medicine, Seoul, South Korea.
Kim MH; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
Sohn J; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
Park YH; Hematology-Oncology, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, South Korea.
Kim JY; Hematology-Oncology, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, South Korea.
Jeong JH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Lee KE; Department of Hematology and Oncology, Ewha Womans University Hospital, Seoul, South Korea.
Choi IS; Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, South Korea.
Park KH; Division of Medical Oncology/Hematology, Department of Internal Medicine, Korea University Anam Hospital, Seoul, South Korea.
Kim HJ; Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, South Korea.
Cho EK; Division of Medical Oncology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea.
Park SY; Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
Kim M; Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea; Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Kim JH; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea. Electronic address: .; Pokaż więcej
Źródło:: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Dec; Vol. 195, pp. 113386. Date of Electronic Publication: 2023 Oct 14.
Typ publikacji:: Clinical Trial, Phase II; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/pathology
Triple Negative Breast Neoplasms*/drug therapy
Adult ; Female ; Humans ; Middle Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; B7-H1 Antigen ; Nivolumab/therapeutic use ; Receptor, ErbB-2/metabolism ; Aged

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 16.

Tytuł:: Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study.
Autorzy:: Morganti S; Breast Oncology Center, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Marra A; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy.
Gandini S; Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milan, Italy.
Ascione L; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Ivanova M; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Venetis K; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Sajjadi E; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Zagami P; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Giugliano F; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; INSERM U981 - Molecular Predictors and New Targets in Oncology, PRISM Center for Precision Medicine, Gustave Roussy, Villejuif, France.
Taurelli Salimbeni B; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy.
Berton Giachetti PPM; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Corti C; Breast Oncology Center, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
De Camilli E; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Curigliano G; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Fusco N; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Criscitiello C; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Electronic address: .; Pokaż więcej
Źródło:: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Dec; Vol. 195, pp. 113397. Date of Electronic Publication: 2023 Oct 23.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/pathology
Triple Negative Breast Neoplasms*
Humans ; Female ; Receptors, Estrogen/metabolism ; Case-Control Studies ; Receptor, ErbB-2/metabolism ; Neoplasm Recurrence, Local ; Prognosis ; Recurrence ; Receptors, Progesterone/metabolism ; Biomarkers, Tumor/metabolism

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 17.

Tytuł:: Survival outcomes seen with neoadjuvant chemotherapy in the management of locally advanced inflammatory breast cancer (IBC) versus matched controls.
Autorzy:: Johnson KC; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
Grimm M; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
Sukumar J; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
Schnell PM; Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, OH, USA.
Park KU; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA; Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, OH, USA.
Stover DG; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
Jhawar SR; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
Gatti-Mays M; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
Wesolowski R; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
Williams N; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
Sardesai S; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
Pariser A; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
Sudheendra P; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
Tozbikian G; Department of Pathology, The Ohio State University, Columbus, OH, USA.
Ramaswamy B; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
Doto D; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
Cherian MA; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA. Electronic address: .; Pokaż więcej
Źródło:: Breast (Edinburgh, Scotland) [Breast] 2023 Dec; Vol. 72, pp. 103591. Date of Electronic Publication: 2023 Oct 14.
Typ publikacji:: Journal Article
MeSH Terms:: Inflammatory Breast Neoplasms*
Breast Neoplasms*/drug therapy
Humans ; Female ; Neoadjuvant Therapy ; Disease-Free Survival ; Retrospective Studies ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Chemotherapy, Adjuvant ; Neoplasm Recurrence, Local/drug therapy ; Prognosis

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 18.

Tytuł:: Neoadjuvant Chemotherapy of Taxanes With or Without Anthracyclines in Different Molecular Subtypes of Breast Cancer: A Propensity Score Matching Study.
Autorzy:: Xiao J; Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China.
Wang T; Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China.
Yi J; Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China.
Huang M; Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China.
Yan C; Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China.
Ling R; Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China. Electronic address: .; Pokaż więcej
Źródło:: Clinical breast cancer [Clin Breast Cancer] 2023 Dec; Vol. 23 (8), pp. 882-893. Date of Electronic Publication: 2023 Sep 14.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Breast Neoplasms*/pathology
Triple Negative Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/genetics
Triple Negative Breast Neoplasms*/pathology
Humans ; Female ; Anthracyclines/therapeutic use ; Retrospective Studies ; Neoadjuvant Therapy ; Propensity Score ; Taxoids/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Receptor, ErbB-2/therapeutic use ; Chemotherapy, Adjuvant

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 19.

Tytuł:: A simple and convenient model combining multiparametric MRI and clinical features to predict tumour-infiltrating lymphocytes in breast cancer.
Autorzy:: Chen S; Department of Radiology, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, 510180, China.
Sui Y; Department of Radiology, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, 510180, China; Department of Radiology, Guangzhou Women and Children's Medical Center, Guangzhou, 510005, China.
Ding S; Department of Radiology, Liuzhou People's Hospital, Guangxi Medical University, Liuzhou, 545006, China.
Chen C; Department of Pathology, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, 510180, China.
Liu C; Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China.
Zhong Z; Department of Radiology, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, 510180, China.
Liang Y; Department of Pathology, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, 510180, China.
Kong Q; Department of Radiology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, China. Electronic address: antony_.
Tang W; Department of Radiology, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, 510180, China. Electronic address: .
Guo Y; Department of Radiology, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, 510180, China. Electronic address: .; Pokaż więcej
Źródło:: Clinical radiology [Clin Radiol] 2023 Dec; Vol. 78 (12), pp. e1065-e1074. Date of Electronic Publication: 2023 Sep 22.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/metabolism
Multiparametric Magnetic Resonance Imaging*
Triple Negative Breast Neoplasms*/metabolism
Triple Negative Breast Neoplasms*/pathology
Humans ; Female ; Retrospective Studies ; Lymphocytes, Tumor-Infiltrating/metabolism ; Lymphocytes, Tumor-Infiltrating/pathology ; Disease-Free Survival ; Prognosis

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 20.

Tytuł:: Commentary: Outcomes of Metaplastic Breast Cancer vs. Triple-Negative Breast Cancer.
Autorzy:: Agarwal G; Sanjay Gandhi Post Graduate Institute of Medical Sciences, Endocrine and Breast Surgery, Lucknow, India. .
Chanthar KMMV; Sanjay Gandhi Post Graduate Institute of Medical Sciences, Endocrine and Breast Surgery, Lucknow, India.; Pokaż więcej
Źródło:: World journal of surgery [World J Surg] 2023 Dec; Vol. 47 (12), pp. 3203-3204. Date of Electronic Publication: 2023 Sep 30.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/therapy
Triple Negative Breast Neoplasms*/therapy
Carcinoma, Ductal, Breast*
Humans ; Female ; Biomarkers, Tumor ; Metaplasia

Czasopismo naukowe

na półce

Szczegóły

Informacja

Wyszukujesz frazę ""Breast Neoplasms"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język